ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Nutriband Inc

Nutriband Inc (NTRB)

4.1109
0.0386
(0.95%)
Closed January 18 4:00PM
4.1109
0.00
(0.00%)
After Hours: 6:37PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
4.1109
Bid
3.89
Ask
4.61
Volume
6,079
4.0852 Day's Range 4.22
2.22 52 Week Range 9.595
Market Cap
Previous Close
4.0723
Open
4.12
Last Trade
25
@
4.05
Last Trade Time
Financial Volume
$ 25,166
VWAP
4.1399
Average Volume (3m)
23,817
Shares Outstanding
11,106,185
Dividend Yield
-
PE Ratio
-8.32
Earnings Per Share (EPS)
-0.49
Revenue
2.09M
Net Profit
-5.49M

About Nutriband Inc

Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically O... Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products. Show more

Sector
Ortho,prosth,surg Appl,suply
Industry
Ortho,prosth,surg Appl,suply
Website
Headquarters
Las Vegas, Nevada, USA
Founded
-
Nutriband Inc is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker NTRB. The last closing price for Nutriband was $4.07. Over the last year, Nutriband shares have traded in a share price range of $ 2.22 to $ 9.595.

Nutriband currently has 11,106,185 shares outstanding. The market capitalization of Nutriband is $45.23 million. Nutriband has a price to earnings ratio (PE ratio) of -8.32.

NTRB Latest News

Nutriband Issues Letter to Shareholders

ORLANDO, Fla., Dec. 31, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders highlighting the...

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Nutriband’s abuse-deterrent platform technology is now patented in 46 countries and territories covering major global markets. Nutriband is targeting to file for FDA approval for AVERSA™ Fentanyl...

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

ORLANDO, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today reported its financial results for the third quarter ended October 31, 2024. The Company...

Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

ORLANDO, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (Nasdaq:NTRB)(Nasdaq:NTRBW) today announced that it will be presenting at the Noble Conference taking place December 3rd and 4th...

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

ORLANDO, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today...

IBN Coverage Initiated for Nutriband Inc.

LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Nutriband Inc. (NASDAQ: NTRB), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1491-3.54.264.383.9167934.14240301CS
4-0.1891-4.39767441864.35.163.7223273294.41550567CS
12-1.6491-28.63020833335.766.43.7223238174.60122998CS
26-2.8891-41.272857142979.5953.7223310215.69047188CS
521.420952.82156133832.699.5952.22340495.04534178CS
156-2.0291-33.04723127046.149.5951.53313874.65310727CS
260-1.3691-24.98357664235.4812.321.533482349.10824665CS

NTRB - Frequently Asked Questions (FAQ)

What is the current Nutriband share price?
The current share price of Nutriband is $ 4.1109
How many Nutriband shares are in issue?
Nutriband has 11,106,185 shares in issue
What is the market cap of Nutriband?
The market capitalisation of Nutriband is USD 45.23M
What is the 1 year trading range for Nutriband share price?
Nutriband has traded in the range of $ 2.22 to $ 9.595 during the past year
What is the PE ratio of Nutriband?
The price to earnings ratio of Nutriband is -8.32
What is the cash to sales ratio of Nutriband?
The cash to sales ratio of Nutriband is 21.9
What is the reporting currency for Nutriband?
Nutriband reports financial results in USD
What is the latest annual turnover for Nutriband?
The latest annual turnover of Nutriband is USD 2.09M
What is the latest annual profit for Nutriband?
The latest annual profit of Nutriband is USD -5.49M
What is the registered address of Nutriband?
The registered address for Nutriband is 3773 HOWARD HUGHES PARKWAY, SUITE 500S, LAS VEGAS, NEVADA, 89169 6014
What is the Nutriband website address?
The website address for Nutriband is nutriband.com
Which industry sector does Nutriband operate in?
Nutriband operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BTCTBTC Digital Ltd
$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
$ 29.97
(45.98%)
19.09M
GSITGSI Technology
$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
$ 137.71
(3.10%)
201.4M

NTRB Discussion

View Posts
Seriously folks Seriously folks 6 months ago
Must have been an interesting webinar….double the volume and down 8%.
👍️0
Monksdream Monksdream 6 months ago
NTRB new 52 week high
👍️0
Seriously folks Seriously folks 7 months ago
Now I’m told “it’ll “ happen 4q 2025….
More baloney….
👍️0
Seriously folks Seriously folks 7 months ago
Now I’m told “it’ll “ happen 4q 2025….
More baloney….
👍️0
Seriously folks Seriously folks 7 months ago
Typical ntrb day…
👍️0
Awl416 Awl416 8 months ago
Solid day
👍️0
Monksdream Monksdream 9 months ago
Wowser! I happen to agree with you.
👍️0
ZigZag1 ZigZag1 9 months ago
It’s under $5 for a reason. Management is just using this company as a lifestyle paycheck.
👍️0
Monksdream Monksdream 9 months ago
NTRB under $5

👍️0
Monksdream Monksdream 10 months ago
NTRB under $5
👍️0
glenn1919 glenn1919 10 months ago
NTRB................................https://stockcharts.com/h-sc/ui?s=NTRB&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 10 months ago
NTRB....MONSTER
👍️0
TrendTrade2016 TrendTrade2016 10 months ago
NTRB...GAPPING INTO OPEN FOR THE SELL
👍️0
glenn1919 glenn1919 10 months ago
NTRB...................................https://stockcharts.com/h-sc/ui?s=NTRB&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 10 months ago
NTRB....PRE TO OPEN BEAST
👍️0
Inve$tor77 Inve$tor77 1 year ago
$NTRB 2.95. Nice buys.
👍️0
ZigZag1 ZigZag1 1 year ago
This will be at a $1.50 by the end of the week. Management sure sold me on this one!
👍️0
ZigZag1 ZigZag1 1 year ago
You’d think it price would reflect news like this. They have to get rid of the word “fentanyl”. It’s so toxic. It’s right up there with ephedrine and OxyContin.
👍️0
Inve$tor77 Inve$tor77 1 year ago
Nice news!

https://www.accesswire.com/785775/nutriband-announces-issuance-of-us-patent-for-transdermal-abuse-deterrent-technology
👍️0
ZigZag1 ZigZag1 1 year ago
I sold everything, I just check back from time to time. I think they are now just using their money for salaries. Their model has the word “fentanyl” in it which is about as toxic as the word “OxyContin”.
👍️0
Seriously folks Seriously folks 1 year ago
What’s going on with this stock?
👍️0
McMagyar McMagyar 2 years ago
Ollie Ollie unkenfraz
👍️0
McMagyar McMagyar 2 years ago
What lurks behind the curtain!
👍️0
stock1ace1 stock1ace1 2 years ago
Registration withdraw low float
👍️0
Monksdream Monksdream 2 years ago
NTRB dead cat and the down trend resumes?
👍️0
Inve$tor77 Inve$tor77 2 years ago
What’s with the huge selling? Seems like big ask
👍️0
Inve$tor77 Inve$tor77 2 years ago
Bid and ask tight. Volume coming in.
👍️0
Inve$tor77 Inve$tor77 2 years ago
Agreed. Once the selling stop perhaps it will rebound back .
👍️0
ZigZag1 ZigZag1 2 years ago
It could. But being out of money is going to make things tough. They definitely need something good to happen for this to pop.
👍️0
Inve$tor77 Inve$tor77 2 years ago
I’m not sure it’s going to hit that low before a nice bounce back. It’s still a low float stock.
👍️0
ZigZag1 ZigZag1 2 years ago
I personally see it at $1. Their revenue comes from k tape that you can get off of Amazon for $5. Their hope is this fentanyl patch. But even if they get approval? I don’t see many Drs wanting to prescribe it, nor patients wanting it. Let’s put it this way; if a dr asked you if you wanted traditional pain meds or a fentanyl patch; what would you want?
👍️0
Inve$tor77 Inve$tor77 2 years ago
Where’s bottom? Should be close for a bounce hopefully.
👍️0
ZigZag1 ZigZag1 2 years ago
It’s like 7.5m outstanding, but now doing an offering of $4m with a market cap of $15m, just simply means they are out of money. This isn’t looking good. I just wish they would change the name to something like “drug deterrent patch” or something. Who would want to keep an investment in fentanyl? That’s a word right up there with OxyContin???
👍️0
Inve$tor77 Inve$tor77 2 years ago
Wasn’t there an offering for $4 mill minus underwriting fees?
I don’t remember the volume being that high. Isn’t that around 1.5 million shares sold.

“Our common stock is traded on the NASDAQ Capital Market under the symbol “NTRB. On June 22, 2023, the last reported sale price of our common stock was $2.48 per share.”
👍️0
ZigZag1 ZigZag1 2 years ago
Dang, they get a patent approved and now it’s tanking. This will give you an idea of how solid their model is.
👍️0
ZigZag1 ZigZag1 2 years ago
Why so much volume today?
👍️0
Inve$tor77 Inve$tor77 2 years ago
New 52 week lows geez. What’s going on?
👍️0
Inve$tor77 Inve$tor77 2 years ago
$2.50s. Looking for a nice bounce possibly . Float is tiny
👍️0
ZigZag1 ZigZag1 2 years ago
I’m not sure their model has the capability of meaningful good news. Anything with the fentanyl in it, proves to be an uphill battle.
👍️0
Inve$tor77 Inve$tor77 2 years ago
With any good news or buying pressure this can take off nicely. Very thin float.
👍️0
Inve$tor77 Inve$tor77 2 years ago
Nice bounce recovery from lows. When good news hits looking forward to a big climb. I saw they filed for a small offering a couple of weeks ago. I’m surprised they did it at this low price.
👍️0
ZigZag1 ZigZag1 2 years ago
Yes they are. But I think it’s going to be an up-hill battle trying to get anything approved with the word “Fentanyl” in it. Talk about FDA scrutiny!
👍️0
Inve$tor77 Inve$tor77 2 years ago
Does anyone know if they are still waiting on FDA approval ?
👍️0
McMagyar McMagyar 2 years ago
Nice day
👍️0
Seriously folks Seriously folks 2 years ago
It looks like this might be turning around….
👍️0
McMagyar McMagyar 3 years ago
Entrepreneurial spirit isn’t dead
Nutriband full steam ahead
👍️0
McMagyar McMagyar 3 years ago
I don’t think market is giving the 3m agreement enough value.they may have a few surprises coming our way
👍️0
Seriously folks Seriously folks 3 years ago
Still heading the wrong direction!
👍️0
Seriously folks Seriously folks 3 years ago
What a disappointment……
👍️0
StocksNcash StocksNcash 3 years ago
I dumped it garbage
👍️0

Your Recent History

Delayed Upgrade Clock